Evidence map›Paper›PMID 40141108›Full record

ArticleInternational journal of molecular sciences2025

Effects of

Fu-Sheng Deng, Miao-Hui Lin, Chin-Lin Huang, Chien-Chen Wu, Ching-Liang Lu, Ying-Chieh Tsai

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Fu-Sheng DengBened Biomedical Co., Ltd., Taipei 115011, Taiwan.
Miao-Hui LinInstitute of Biochemistry and Molecular Biology, National Yang Ming Chiao Tung University, Taipei 11221, Taiwan.
Chin-Lin HuangBened Biomedical Co., Ltd., Taipei 115011, Taiwan.
Chien-Chen WuBened Biomedical Co., Ltd., Taipei 115011, Taiwan.ORCID 0000-0002-9099-8761
Ching-Liang LuSchool of Medicine, National Yang Ming Chiao Tung University, Taipei 11221, Taiwan.
Ying-Chieh TsaiInstitute of Biochemistry and Molecular Biology, National Yang Ming Chiao Tung University, Taipei 11221, Taiwan.ORCID 0000-0002-4390-4742

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder marked by abdominal pain and irregular bowel habits. Recently, more and more evidence supports gut microbiota imbalance in IBS and highlights the potential of probiotics in restoring gut health and reducing symptoms. In this study, we explored the effects of

Indexed as

5-HydroxytryptophanIrritable Bowel SyndromeLactococcusProbioticsAnimalsColonDisease Models, AnimalGastrointestinal MicrobiomeMaleRatsRats, Sprague-DawleySerotonin5-HydroxytryptophanSerotoningut microbiotairritable bowel syndromeLactococcus cremorisPS133

Identifiers

PMID40141108
PMCPMC11942017

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.